ORLANDO, Fla., Feb. 19 /PRNewswire-FirstCall/ -- Telzuit Medical Technologies, Inc. (BULLETIN BOARD: TZMT) announced that it has successfully migrated its STATPATCH Holter Monitor software to a Windows- Mobile and Windows environment. This platform will enable Telzuit to use a variety of PDA's that work on a Windows-Mobile operating system. The Company believes it will also be able to use the STATPATCH system directly on PC's utilizing Windows. The next steps for the Company are to synchronize the patch to the Windows and Windows-Mobile solution and then to test the product in a real time setting.
The Company still has had problems using the Palm Treo system. The problems with the Palm were replicated by the Company's outside consulting firm, who along with the Palm engineers are continuing to test solutions to these problems.
While no time frame has been set to solve these problems, Telzuit still hopes to release the STATPATCH Holter Monitor System for general release during the current fiscal year.
About Telzuit Medical Technologies, Inc.
Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine to patients. The STATPATCH System is a full 12-lead, completely wireless Holter monitor. The STATPATCH System has been approved by the FDA under a 510-K filing. Telzuit also operates two walk-in medical clinics in the Orlando area and provides ultrasound medical imaging services to physicians in Central Florida through six mobile imaging units. Telzuit is based in Orlando. For more information about Telzuit, its business model and its products, please visit the Company's web site: http://www.telzuit.com/
Forward Looking Statements: Except for factual statements made herein, the information contained in this press release consists of forward looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.
Contact:
Jerry Balter
Chief Financial Officer
Telzuit Medical Technologies, Inc.
407-354-1222
